As immunotherapy for cancer continues to evolve—so has the Association of Community Cancer Centers—adapting to meet the changing needs of the oncology community.
The ACCC Immuno-Oncology Institute is the only initiative dedicated to educating multidisciplinary teams to go beyond a clinical understanding of IO and tackle real-world implementation issues. With the care of patients on immunotherapies now extending beyond the cancer team, the ACCC Immuno-Oncology Institute is at the forefront of developing critical education to empower healthcare professionals across care delivery settings.
Under the guidance of the IO Institute Executive Committee, multispecialty Working Groups were established to focus on Big Data, Telemedicine, Care Coordination and Communication, and Training and Education. IO Working Groups members share their expertise, knowledge, and forward-looking perspectives to provide a framework for developing proactive strategies for effective delivery of these new and emerging therapies.
As part of the Immuno-Oncology Institute, ACCC is leading numerous projects to support multidisciplinary teams in care delivery for cancer immunotherapies.
Download End of Year Publication
An Evidence-Based Argument Is Often the Fastest Route to Immunotherapy Authorization - via OncLive
Telemedicine working group aims to address ‘big gaps’ of emergency cancer care - via HemOnc Today
Download IO Wallet Card
Download Article & Companion Guide
See All Immuno-Oncology Insights